In one paragraphArticle in JCO precision oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
3 authors.
Robert A BeckmanRobert A. Beckman, MD, Departments of Oncology and of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center and Innovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC; Alvin P. Makohon-Moore, PhD, Hackensack Meridian Health Center for Discovery and Innovation, Nutley, NJ, Georgetown University Lombardi Comprehensive Cancer Center, Washington, DC; and Igor Puzanov, MD, MS, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY.ORCID 0000-0003-0098-9210 Alvin P Makohon-MooreRobert A. Beckman, MD, Departments of Oncology and of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center and Innovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC; Alvin P. Makohon-Moore, PhD, Hackensack Meridian Health Center for Discovery and Innovation, Nutley, NJ, Georgetown University Lombardi Comprehensive Cancer Center, Washington, DC; and Igor Puzanov, MD, MS, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY.ORCID 0000-0002-4781-3565 Igor PuzanovRobert A. Beckman, MD, Departments of Oncology and of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center and Innovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC; Alvin P. Makohon-Moore, PhD, Hackensack Meridian Health Center for Discovery and Innovation, Nutley, NJ, Georgetown University Lombardi Comprehensive Cancer Center, Washington, DC; and Igor Puzanov, MD, MS, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY.ORCID 0000-0002-9803-3497 Funding
Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6MExperimental evolution of pancreatic cancerR00CA229979 · NCI · HACKENSACK UNIVERSITY MEDICAL CENTER · PI MAKOHON-MOORE, ALVIN · 2022 to 2024
$747kNCI NIH HHS P30 CA016056NCI NIH HHS R00 CA229979
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID37285558
PMCPMC10309574
What OpenQuestion holds
Textmetadata
Read underepoch 390